Health & Medicine Second line therapy for nsclc

1. New Perspectives on Second-Line Therapy for NSCLC Tony Mok, MD (Moderator) Professor, Department of Clinical Oncology, Chinese University of Hong Kong; Honorary Consultant,…

Documents PARAMOUNT: phase III study of pemetrexed continuation maintenance therapy in advanced non-squamous.....

Slide 1PARAMOUNT: phase III study of pemetrexed continuation maintenance therapy in advanced non-squamous NSCLC. Slide 2 All Chapters at a glance: please click on box to…